TR200000333T2 - Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler. - Google Patents

Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.

Info

Publication number
TR200000333T2
TR200000333T2 TR2000/00333T TR200000333T TR200000333T2 TR 200000333 T2 TR200000333 T2 TR 200000333T2 TR 2000/00333 T TR2000/00333 T TR 2000/00333T TR 200000333 T TR200000333 T TR 200000333T TR 200000333 T2 TR200000333 T2 TR 200000333T2
Authority
TR
Turkey
Prior art keywords
aminopyrol
pyrimidines
receptor antagonists
neuropeptide
excess
Prior art date
Application number
TR2000/00333T
Other languages
English (en)
Inventor
Lee Dow Robert
Hammond Marlys
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200000333T2 publication Critical patent/TR200000333T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nöropeptid Y'nin fazlaligiyla iliskilendirilen kosullarin tedavisi için formül (I) bilesimleri
TR2000/00333T 1997-08-05 1998-07-10 Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler. TR200000333T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5473497P 1997-08-05 1997-08-05

Publications (1)

Publication Number Publication Date
TR200000333T2 true TR200000333T2 (tr) 2000-05-22

Family

ID=21993163

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00333T TR200000333T2 (tr) 1997-08-05 1998-07-10 Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.

Country Status (32)

Country Link
US (1) US6187778B1 (tr)
EP (1) EP1003744B1 (tr)
JP (1) JP3711238B2 (tr)
KR (1) KR20010022583A (tr)
CN (1) CN1264381A (tr)
AP (1) AP9801312A0 (tr)
AT (1) ATE296825T1 (tr)
AU (1) AU7927498A (tr)
BG (1) BG104107A (tr)
BR (1) BR9811844A (tr)
CA (1) CA2293621C (tr)
CO (1) CO4960634A1 (tr)
DE (1) DE69830409T2 (tr)
EA (1) EA200000098A1 (tr)
ES (1) ES2241146T3 (tr)
GT (1) GT199800114A (tr)
HR (1) HRP980434A2 (tr)
HU (1) HUP0002956A3 (tr)
ID (1) ID24300A (tr)
IL (1) IL133430A0 (tr)
IS (1) IS5294A (tr)
MA (1) MA24629A1 (tr)
NO (1) NO996178L (tr)
OA (1) OA11277A (tr)
PA (1) PA8456601A1 (tr)
PE (1) PE106199A1 (tr)
PL (1) PL338575A1 (tr)
SA (1) SA98190435A (tr)
TN (1) TNSN98148A1 (tr)
TR (1) TR200000333T2 (tr)
WO (1) WO1999007703A1 (tr)
ZA (1) ZA986968B (tr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
ATE347553T1 (de) * 1999-09-30 2006-12-15 Neurogen Corp Amino-substituierte pyrazolo 1,5-aö-1,5- pyrimidine und pyrazolo 1,5-aö-1,3,5-triazine
OA12514A (en) * 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
US7507740B2 (en) 2004-06-02 2009-03-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
NZ552093A (en) 2004-06-17 2009-06-26 Wyeth Corp Processes for preparing gonadotropin releasing hormone receptor antagonists
MXPA06014798A (es) 2004-06-17 2007-06-22 Wyeth Corp Antagonistas del receptor de hormona para liberar gonadotropina.
MX2007001399A (es) * 2004-08-02 2007-04-18 Osi Pharm Inc Compuestos que inhiben pirrolopirimidina multi-cinasa aril-amino sustituidas.
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
KR20060087386A (ko) * 2005-01-28 2006-08-02 주식회사 대웅제약 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
KR101099303B1 (ko) * 2005-01-28 2011-12-26 주식회사 대웅제약 신규한 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
AU2006235200A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of Neuropeptide Y (NPY) and agonists and antagonists thereof for tissue regeneration
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
EP1905769B1 (en) * 2005-07-13 2017-03-29 Msd K.K. Heterocycle-substituted benzimidazole derivative
UY29823A1 (es) * 2005-10-03 2007-05-31 Astrazeneca Ab Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
AR055669A1 (es) * 2005-10-03 2007-08-29 Astrazeneca Ab Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
JP5205276B2 (ja) * 2005-12-22 2013-06-05 ジ インスティテュート オブ キャンサー リサーチ：ロイヤル キャンサー ホスピタル 酵素阻害剤
EP1987030B1 (en) 2006-02-17 2011-11-09 Pfizer Limited 3 -deazapurine derivatives as tlr7 modulators
ES2878130T3 (es) 2006-04-25 2021-11-18 Astex Therapeutics Ltd Derivados de purina y deazapurina como compuestos farmacéuticos
KR101134239B1 (ko) 2006-07-11 2012-04-10 주식회사 대웅제약 신규한 바이아릴 벤조이미다졸 유도체 및 이를 함유하는 약학 조성물
US8436022B2 (en) * 2006-07-11 2013-05-07 Daewoong Pharmaceutical Co., Ltd. Biaryl benzolmidazole derivatives and pharmaceutical composition comprising the same
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008121064A1 (en) * 2007-03-30 2008-10-09 Astrazeneca Ab New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
RS53552B1 (en) 2007-10-11 2015-02-27 Astrazeneca Ab DERIVATI PIROLO [2,3-D] PIRIMIDINA KAO INHIBITORI PROTEIN KINAZE B
BRPI0906475A2 (pt) 2008-01-11 2015-07-14 Natco Pharma Ltd Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
US9402847B2 (en) 2011-04-01 2016-08-02 Astrazeneca Ab Combinations comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
CN103945849B (zh) 2011-11-30 2017-04-26 阿斯利康(瑞典)有限公司 癌症的联合治疗
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
CN113271938A (zh) * 2018-11-30 2021-08-17 林伯士拉克许米公司 Tyk2抑制剂和其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
DE2818676A1 (de) * 1978-04-27 1979-11-08 Troponwerke Gmbh & Co Kg Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
US5877178A (en) * 1991-04-08 1999-03-02 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5284971A (en) 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
EP0580550B1 (en) 1992-07-21 1997-10-22 Novartis AG Oxamic acid derivatives as hypocholesteremic agents
DE59500788D1 (de) * 1994-05-03 1997-11-20 Ciba Geigy Ag Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
BR9509048A (pt) * 1994-09-29 1998-01-06 Novartis Ag Pirrol (2,3-d) pirimidinas e seu uso
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
JP3386814B2 (ja) 1994-11-07 2003-03-17 ファイザー・インコーポレーテッド ある種の置換ベンジルアミン誘導体：新種の神経ペプチドｙ１特異的リガンド
US5644057A (en) * 1995-05-12 1997-07-01 Neurogen Corporation Deazapurine derivatives; a new class of CRF1 specific ligands
EP0759441A3 (en) 1995-06-30 1999-06-30 Eli Lilly And Company Methods of treating neuropeptide Y-associated conditions
JP2000501107A (ja) 1996-01-09 2000-02-02 イーライ・リリー・アンド・カンパニー ベンズイミダゾリル神経ペプチドｙ受容体アンタゴニスト

Also Published As

Publication number Publication date
NO996178L (no) 2000-02-14
CO4960634A1 (es) 2000-09-25
KR20010022583A (ko) 2001-03-26
ZA986968B (en) 2000-02-04
PL338575A1 (en) 2000-11-06
NO996178D0 (no) 1999-12-14
IS5294A (is) 1999-12-10
MA24629A1 (fr) 1999-04-01
BR9811844A (pt) 2000-08-08
OA11277A (en) 2003-07-29
ID24300A (id) 2000-07-13
HUP0002956A3 (en) 2002-01-28
ATE296825T1 (de) 2005-06-15
TNSN98148A1 (fr) 2005-03-15
EA200000098A1 (ru) 2000-08-28
GT199800114A (es) 2000-01-18
EP1003744B1 (en) 2005-06-01
PA8456601A1 (es) 2000-05-24
PE106199A1 (es) 1999-11-02
SA98190435A (ar) 2005-12-03
IL133430A0 (en) 2001-04-30
HUP0002956A2 (hu) 2001-08-28
WO1999007703A1 (en) 1999-02-18
DE69830409T2 (de) 2006-01-26
BG104107A (bg) 2000-08-31
AU7927498A (en) 1999-03-01
CA2293621A1 (en) 1999-02-18
JP3711238B2 (ja) 2005-11-02
CA2293621C (en) 2003-12-30
JP2001512729A (ja) 2001-08-28
US6187778B1 (en) 2001-02-13
ES2241146T3 (es) 2005-10-16
DE69830409D1 (de) 2005-07-07
CN1264381A (zh) 2000-08-23
EP1003744A1 (en) 2000-05-31
HRP980434A2 (en) 1999-04-30
AP9801312A0 (en) 2000-01-30

Similar Documents

Publication Publication Date Title
TR200000333T2 (tr) Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.
SE9702773D0 (sv) Novel compounds
TR199801255T2 (tr) Vitronektin reseptör antagonistleri.
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
TR200102800T2 (tr) Yeni bileşikler.
TR200000014T2 (tr) Yeni ikameli imidazol bileşimleri.
ATE100448T1 (de) Substituierte chinazolinone als angiotensin iiantagonisten.
ATE356119T1 (de) Pyrimidinone als melanin concentrating hormone receptor 1
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
IL148903A0 (en) Certain alkylene diamine-substituted heterocycles
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
BR9910621A (pt) Novos compostos de imidazol 2-alquil substituìdos
EA199900693A1 (ru) Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
BR0007864A (pt) Composto, e, uso de um composto
BG99863A (en) Antagonists of fibrogenous receptor
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
BR9902084A (pt) Heterociclos.
CA2244621A1 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ECSP982616A (es) 4- aminopinol (3,2-d) pirimidinas como antagonistas del receptor del neuropeptido
MXPA01008189A (es) Proceso para la preparacion de compuestos 6-)perfluoroalquil) uracilo a partir de compuestos de urea.
PT1140932E (pt) Derivados de 1,8-benzonaftiridina